Related Experiment Video
Updated: May 24, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Disease risk prediction with rare and common variants
Chengqing Wu1, Kyle M Walsh, Andrew T Dewan
1Department of Epidemiology and Public Health, Yale University, 60 College Street, New Haven, CT 06510, USA. chengqing.wu@yale.edu.
Rare genetic variants significantly improve disease risk prediction, offering greater accuracy than common variants alone. This finding highlights the importance of rare variants in understanding complex disease susceptibility.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Previous research indicates common genetic variants offer limited predictive value for complex diseases beyond established risk factors.
- Advancements in sequencing technology enable the identification of rare genetic variants with potentially greater functional impact.
Purpose of the Study:
- To evaluate the predictive value of rare genetic variants in complex disease risk assessment.
- To compare the performance of prediction models with and without the inclusion of rare variants.
Main Methods:
- Utilized simulated datasets from the Genetic Analysis Workshop 17 (GAW17) comprising unrelated individuals.
- Employed the support vector machine (SVM) algorithm to build disease risk prediction models.
- Compared model discrimination power using common variants versus models incorporating both common and rare variants.
Main Results:
- Empirical results demonstrate that rare variants contribute substantially to disease risk prediction.
- Models incorporating rare variants showed improved predictive capabilities compared to those relying solely on common variants.
Conclusions:
- Rare genetic variants possess appreciable effects on disease risk prediction.
- Incorporating rare variants enhances the quantification of genetic risk, leading to more accurate disease prediction models.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenomics: Identification of New Drug Targets
Single Nucleotide Polymorphisms-SNPs
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...